Pulmonary Hypertension
Conditions
Brief summary
Registry Data from PH-patients in Switzerland, who have given consent to records for research purposes.
Interventions
None listed
Sponsors
Actelion
University of Zurich
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients with PH
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 6-minute walking distance | within the study duration e.g. up to 10 years | 6-minute walking distance |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| New York Heart Association functional class | within the study duration e.g. up to 10 years | New York Heart Association functional class |
| NTproBNP | within the study duration e.g. up to 10 years | NTproBNP |
| Survival | within the study duration e.g. up to 10 years | time to death analysis |
| Medication | within the study duration e.g. up to 10 years | escalation of clinical therapy |
Countries
Switzerland
Contacts
Primary ContactSilvia Ulrich, Prof. Dr.
Outcome results
None listed